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Abstract
Background: During the last years engineered nanoparticles (NPs) have been extensively used in
different technologies and consequently many questions have arisen about the risk and the impact
on human health following exposure to nanoparticles. Nevertheless, at present knowledge about
the cytotoxicity induced by NPs is still largely incomplete. In this context, we have investigated the
cytotoxicity induced by gold nanoparticles (AuNPs), which differed in size and purification grade
(presence or absence of sodium citrate residues on the particle surface) in vitro, in the human
alveolar type-II (ATII)-like cell lines A549 and NCIH441.
Results: We found that the presence of sodium citrate residues on AuNPs impaired the viability
of the ATII-like cell lines A549 and NCIH441. Interestingly, the presence of an excess of sodium
citrate on the surface of NPs not only reduced the in vitro viability of the cell lines A549 and
NCIH441, as shown by MTT assay, but also affected cellular proliferation and increased the release
of lactate dehydrogenase (LDH), as demonstrated by Ki-67 and LDH-release assays respectively.
Furthermore, we investigated the internalization of AuNPs by transmission electron microscopy
(TEM) and we observed that particles were internalized by active endocytosis in the cell lines A549
and NCIH441 within 3 hr. In addition, gold particles accumulated in membrane-bound vesicles and
were not found freely dispersed in the cytoplasm.
Conclusion: Our data suggest that the presence of contaminants, such as sodium citrate, on the
surface of gold nanoparticles might play a pivotal role in inducing cytotoxicity in vitro, but does not
influence the uptake of the particles in human ATII-like cell lines.
Background
Nanoparticles (NPs) are generally defined as having a
diameter below 100 nm and they are believed to display
different properties compared to their bulk material [1-4].
NPs are currently being used extensively in different
industrial technologies, in biomedical applications [5-7]
and in cosmetics [8]. The main route of exposure to NPs
is the respiratory tract, but the human organism can come
into contact with particles via ingestion, deposition and
injection. The epithelial surface area of a human lung,
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mous number of inhaled nanosized materials with each
breath. Inhaled nanoparticles are then deposited along
the respiratory tract depending on their size: discrete
inhaled nanoparticles preferentially accumulate in the
nasal region, while smaller NPs are able to reach the deep
lung, inducing inflammation and the formation of reac-
tive oxidative species in the alveolar region [10-12]. In
addition, the alveolar region, which is composed of many
different cell types in close association to the endothelium
and therefore connected to the blood circulation, is con-
sidered to be a privileged site for NPs deposition and
translocation. It has been shown that after being internal-
ized NPs are able to escape their site of deposition, enter-
ing the blood or the lymphatic circulation and
redistributing to other organs, such as the liver and the
central nervous system [13-16]. Thus, for example, in rats
inhaled ultrafine titanium dioxide NPs have been shown
to be taken up and rapidly redistributed from the lung
compartment to the circulation [17-19]. In humans,
inhaled carbon nanoparticles were reported to translocate
from the lung tissue into the blood stream and become
distributed in extrapulmonary sites [20]. However, due to
the complexity of the pulmonary system, as well as the
increasing number of NPs released in the environment, a
systematic evaluation of nanoparticles-mediated cytotox-
icity has not as yet been possible.
Currently gold nanoparticles (AuNPs) are used in differ-
ent biomedical applications, such as intracellular gene
regulation [21], chemotherapy [22] and drug delivery
[5,6], as well as in optical and electronic applications [23].
Investigations on the in vitro cytotoxicity of gold nanopar-
ticles have already been performed, but so far results were
inconclusive. AuNPs were shown to induce cytotoxicity in
Cos-1 cells [24] and in human dermal fibroblasts [25],
but not in human leukemic cells [26] or murine macro-
phages [27], where particles were taken up and stored in
intracellular perinuclear vesicles. In addition, it is still
unknown whether the size or the surface coating of the
gold nanosized particles induces cellular damage and
cytotoxicity in vitro. In this context, Pan et al. [28] have
shown that the size of the particles plays a pivotal role in
inducing cytotoxicity in HeLa cells. They have demon-
strated that small AuNPs (1–2 nm size), but not the larger
(15 nm size), could induce toxicity in HeLa cells. On the
other hand, Niidome et al. [29] have shown that the toxic
potential is triggered by the surface modification of the
gold nanoparticles. In fact, bromide-stabilized gold nano-
rods induced severe cytotoxicity in HeLa cells, whereas
PEG-modified gold particles, which displayed a neutral
surface, could only induce moderate toxicity. Neverthe-
less, Connor et al. [26] demonstrated that neither the sur-
face characteristics nor the size of gold nanoparticles
seemed to play a role in inducing cytotoxicity in the
human leukemic cell line K562. In fact, they indicated
that gold nanoparticles with different size and surface
modifications could be internalized by the cells but did
not exert cytotoxicity. On the basis of this the authors pro-
posed that the shape of the NPs, and eventually intracel-
lular modifications of the nanoparticles determined by
the cellular environment, could be responsible for causing
toxicity.
Due to the contradictory results of the previous investiga-
tions, the present study was aimed at examining the effect
of gold nanoparticles in the deep respiratory tract. To this
end, the human alveolar type-II (ATII)-like cell lines A549
and NCIH441 were exposed to AuNPs with different
diameter (9.5 – 25 nm) and purification grade (presence
or absence of an excess of sodium citrate), and the toxicity
induced was evaluated by classical cytotoxicity assays.
Briefly, we demonstrated that gold nanoparticles with an
excess of sodium citrate impaired the viability, the mem-
brane integrity and the proliferation of the human ATII-
like cell lines A549 and NCIH441 in vitro. As a result, we
then examined whether the non-toxic potential of the
gold nanoparticles without sodium citrate was due to an
impaired uptake of the particles. By transmission electron
microscopy (TEM) we observed that AuNPs were indeed
internalized by the ATII-like cell lines A549 and
NCIH441, independent of the presence or absence of con-
taminants on the particle surface, and independent of the
size and the shape of the particles.
Results and Discussion
Synthesis and characterization of gold nanoparticles
Water-dispersed gold nanoparticles (AuNPs) were synthe-
sized by wet chemical synthesis based on the reduction of
tetrachloroauric acid. Three AuNPs batches were pro-
duced (AuS0302; AuS0302-RIS02; AuS0302-RIS04) and
consequently analyzed to identify their physicochemical
properties. Dynamic light scattering (DLS) indicated that
the batch AuS0302 had a large dispersion of the particles
(polydispersity index PDI ≥ 0.3), with an average volume-
weighted diameter of 21.42 nm (Table 1). The hydrody-
namic diameter was not modified, although AuNPs
underwent purification and dialysis to reduce the excess
of sodium citrate retained during the synthesis, and
indeed the hydrodynamic diameter increased for the sam-
ples AuS0302-RIS02 and AuS0302-RIS04, suggesting that
the experimental procedure adopted to produce particles
with increasing diameter was successful (Table 1). Parti-
cles were further analyzed by scanning transmission elec-
tron micrographs (STEM). As shown in Figure 1, particles
did not form large aggregates and they were quite uni-
formly dispersed. Interestingly, STEM revealed that the
gold nanoparticles had a smaller diameter and narrower
size distribution compared to the results obtained by DLS
(Table 1). In fact, over 200 AuNPs were analyzed, and thePage 2 of 12
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nm, 11.19 nm and 25.0 nm for AuS0302, AuS0302-RIS02
and AuS0302-RIS04 respectively. As large PDI were
observed, it was not possible to convert the volume-
weighted diameter from dynamic light scattering meas-
urement to the number-weighted diameter calculated
from electron microscopy images. In this case electron
microscopy gives more reliable results, as it is a direct
measurement of the diameter and confirms that the pro-
posed synthetic method is effective in producing nanopar-
ticles of increasing size.
To remove the excess of sodium citrate retained during the
synthesis, the sample AuS0302 underwent filtration and
dialysis, and the purified product was identified as
AuS0302-RIT. The physicochemical properties of the par-
ticles were preserved during tangential flow filtration
(Table 1), and this procedure did not induce nanoparticle
agglomeration, as was shown by STEM (Figure 1). Analy-
sis of the dried permeate by differential scanning calorim-
etry – thermogravimetry (DSC-TG) revealed that by
filtration nearly 92% of sodium citrate was removed from
the final filtrate solution AuS0302-RIT (data not shown).
Nevertheless, the presence of PVP residues on the surface
of the gold nanoparticles cannot be excluded. In addition,
Characterization of the gold nanoparticles using scanning transmission electron microscopyFigure 1
Characterization of the gold nanoparticles using scanning transmission electron microscopy. Water dispersed 
gold nanoparticles were analyzed by scanning transmission electron microscopy (STEM) to determine their size, shape and dis-
tribution. AuS0302 (A), AuS0302-RIT (B), AuS0302-RIS02 (C) and AuS0302-RIS04 (D) appeared monodispersed in solution or 
formed small aggregates, and their diameter ranged between 5 nm (A) and 25 nm (D). With the exception of the sample 
AuS0302-RIS04, all particles synthesized displayed a spherical shape.Page 3 of 12
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Table 1: Physicochemical characterization of the gold nanoparticles.
Samples Solvent %Au w/w PDI dV mean (nm) D STEM (nm)
AuS0302 H2O 0.259 0.362 21.42 9.44
AuS0302-RIT H2O 0.256 0.330 21.20 9.79
AuS0302-RIS02 H2O 0.282 0.331 27.17 11.19
AuS0302-RIS04 H2O 0.288 0.362 28.18 25.0
Water-dispersed gold nanoparticles were produced by wet chemical reaction based on the reduction of tetrachloroauric acid. This technique 
allowed the synthesis of nanoparticles with increasing diameter, as shown by DLS and STEM.
PDI: polydispersity index
dV: mean diameter calculated by dynamic light scattering (DLS)
D STEM: scanning transmission electron micrographs
Comparison of the viability of the cell lines A549 and NCIH441 exposed to gold nanoparticlesFigure 2
Comparison of the viability of the cell lines A549 and NCIH441 exposed to gold nanoparticles. The cell lines 
A549 (A) and NCIH441 (B) in the logarithmic growth phase were exposed to AuNPs for 24, 48 and 72 hr. The cell viability 
was measured by the MTT assay as described in the Experimental Section. Each result represents the mean viability ± standard 
deviation (SD) of three independent experiments and each of these was performed in triplicate. Cell viability was calculated as 
the percentage of the viable cells compared to the untreated controls.
Particle and Fibre Toxicology 2009, 6:18 http://www.particleandfibretoxicology.com/content/6/1/18possible effects on the particles surface following dialysis
were investigated by measuring the Zeta potential of the
particles, revealing that the Zeta potential before (-13 ± 2
mV) and after (-12 ± 2 mV) dialysis did not change.
Cytotoxicity of gold nanoparticles
MTT assay
To examine the cytotoxicity of gold nanoparticles
(AuNPs), monocultures of the human alveolar type-II-like
cell lines A549 and NCIH441 were incubated with
increasing amounts of AuNPs for 24–72 hr, and the cell
viability, expressed as percentage of the untreated control
(100% cell viability), was investigated by 3-(4,5-dimeth-
ylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay. Figure 2A shows that AuS0302-RIT nanoparticles
did not have any effect on the viability of the human ATII-
like cell line A549, while AuS0302-RIS02 and AuS0302-
RIS04, which present an excess of sodium citrate on their
surface, only exerted a mild toxicity at high concentrations
(0.7 mM). Even after 72 hr continuous exposure to Au/
sodium citrate nanoparticles, 60–70% cell viability could
be detected. Interestingly, as shown in Figure 2B, by the
MTT assay gold-induced cytotoxicity in monoculture of
the human ATII-like cell line NCIH441 could not be
detected. Our data are consistent with previous investiga-
tions in which citrated and biotinylated gold nanoparti-
cles were shown to be non-toxic in the human leukemia
cell line K562 [26] and colloidal and lysine-capped
AuNPs did not exert any effect in the mouse macrophage
cell line RAW264.7 [27]. Connor [26] and Shukla [27]
could not detect any decrease in the cell viability after
exposing cells to nanoparticles presenting citrate, biotin
and borohydride as surface modification, and, as shown
by MTT assay, after 72 hr exposure the human leukemia
cell line K562 and the mouse macrophage cell line
RAW264.7 were still viable.
Comparison of the proliferation of the cell lines A549 and NCIH441 exposed to gold nanoparticlesFigure 3
Comparison of the proliferation of the cell lines A549 and NCIH441 exposed to gold nanoparticles. The cell lines 
A549 (A) and NCIH441 (B) in the logarithmic growth phase were exposed to AuNPs for 24, 48 and 72 hr. Each result repre-
sents the mean proliferation ± standard deviation (SD) of three independent experiments and each of these was performed in 
triplicate. Cell proliferation was calculated as the percentage of the viable cells compared to the untreated controls.Page 5 of 12
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The gold-mediated cytotoxicity on the human ATII-like
cell lines A549 and NCIH441 was further investigated by
Ki-67 assay for cell proliferation. As for the MTT assay,
cells were exposed to AuNPs for 24–72 hr. As shown in
Figure 3A, when exposing the ATII-like cell line A549 to
citrated nanoparticles AuS0302-RIS02 and AuS0302-
RIS04 a dose- and time-dependent impairment of prolif-
eration was observed. Compared to the untreated control,
after 24 hr the proliferation of the cell line A549 was
reduced by about 50%, and following longer incubation
periods (48–72 hr) only 20–30% proliferation could be
measured in the presence of gold nanoparticles. AuS0302-
RIS02 and AuS0302-RIS04 exerted a milder effect on the
proliferation of the human ATII-like cell line NCIH441
(Figure 3B), similar to that observed in the MTT assay.
After 24, 48 or 72 hr exposure to gold nanoparticles with
an excess of sodium citrate, 40–60% proliferating
NCIH441 cells could be detected, and the same pattern
could be observed upon comparing the different exposure
periods. The results obtained from exposing the human
ATII-like cell lines A549 and NCIH441 to the gold nano-
particles AuS0302-RIT were of special interest. AuS0302-
RIT, which contained a reduced amount of sodium citrate
as surface contaminant, slightly impaired the prolifera-
tion of the ATII-like cell line A549: only a 20–30% reduc-
tion in the proliferation of the cell line A549 was
measured at 48–72 hr incubation with AuS0302-RIT (Fig-
ure 3A). Similarly, the cell line NCIH441 did not show
any reduced proliferation after 24–72 hr incubation with
AuS0302-RIT nanoparticles (Figure 3B). Taken together,
the proliferation of the cell line NCIH441 was less affected
by the presence of gold nanoparticles compared to the
ATII-like cell line A549, and in general the presence of
sodium citrate appeared to lead to a reduction in the pro-
liferation of the ATII-like cell lines A549 and NCIH441 in
vitro.
Lactate dehydrogenase (LDH) release assay
To further investigate the possible cytotoxicity induced by
gold nanoparticles on human type-II-like pneumocytes in
vitro, the cell lines A549 and NCIH441 were exposed to
gold nanoparticles and the amount of LDH released,
which is a sensitive and accurate marker for cellular toxic-
ity, was evaluated. Figure 4A clearly shows that after 24–
48 hr exposure gold nanoparticles induced a mild LDH
release in the human ATII-like cell line A549, independ-
ent of the presence or absence of surface contaminants. In
addition, after 72 hr exposure to AuNPs a dose-dependent
release of lactate dehydrogenase in the supernatant was
observed and the amount of LDH released was signifi-
cantly higher compared to shorter exposure times (24–48
hr) (Figure 4A). Interestingly, we observed a comparable
LDH release after 24–48 hr treatment to 0.7 mM AuNPs,
and the lactate dehydrogenase release increased signifi-
cantly after 72 hr continuous exposure. The same results
were obtained when the cell line NCIH441 was exposed
to gold nanoparticles. As shown in Figure 4B, after 24–48
hr exposure, the amount of LDH was significantly lower
compared to the 72 hr time point and, as already observed
in the cell line A549, the release of LDH after 72 hr expo-
sure was dose-dependent. Interestingly, in the presence of
gold nanoparticles the cell line NCIH441 released a
higher amount of LDH compared to the cell line A549. As
for the cell line A549, the presence of an excess of sodium
citrate on the particle surface increased the secretion of
LDH in the supernatants of the cell line NCIH441 after 72
hr exposure.
To summarize, the presence of sodium citrate on the sur-
face of gold nanoparticles reduced the viability (as shown
by MTT assay) and impaired the proliferation (as demon-
strated by Ki-67 assay) in both the human ATII-like cell
lines A549 and NCIH441. In addition, the results
obtained by MTT and Ki-67 assay suggest that the cell line
NCIH441 is slightly more resistant to the AuNPs-induced
cytotoxicity compared to the cell line A549. However, our
data indicate that it is the presence of contaminants, such
as sodium citrate, and not the size of the particles that
impairs the viability and the proliferation of the cell lines
A549 and NCIH441. These results are consistent with pre-
vious investigations performed with dermal fibroblasts
[25] and leukemic cells [26]. Pernodet et al. [25] demon-
strated that gold/citrate nanoparticles impaired the prolif-
eration of dermal fibroblasts and induced an abnormal
formation of actin filaments, causing therefore a reduced
cellular motility and influencing the cell morphology. On
the contrary, Connor et al. [26] reported that citrated and
biotinylated 18 nm AuNPs did not induce toxicity in
leukemic cells (cell line K562), whereas smaller particles
were much more toxic. In addition, gold nanoparticles
did not exert any toxic effect, as shown by the MTT assay,
in the human gastrointestinal cancer cells Panc-1 and
HepB3 [30], nor in HeLa cells [27,31]. Hauck et al. [31]
have demonstrated that the use of different surface coat-
ings does not influence the toxicity induced by gold nan-
oparticles in HeLa cells, but it was of extreme importance
to tune the uptake of AuNPs. In addition, Hauck et al. [31]
suggest that the lack of toxicity was due to the fact that
AuNPs were stored intracellularly in membrane-bound
vesicles and therefore particles could not directly interfere
with the nuclei or with other cytoplasmic organelles and
induce toxic events. Nevertheless, there is evidence that
the size of the gold nanoparticles induces in vitro cytotox-
icity in HeLa cells. In fact, Pan et al. [28] have shown that
the size, and not the particle chemistry, is responsible for
determining the toxicity of the gold particles. After expos-
ing for 48 hr the cells to increasing concentrations of
nanosized gold particles, by MTT assay Pan et al. observed
that Au clusters of different sizes had a different toxicPage 6 of 12
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different particles stabilizers, the toxicity observed was
almost indistinguishable, leading the authors to conclude
that it is the size of the particles to play a pivotal role in
inducing in vitro cytotoxicity.
Citrate is commonly used as reducing agent and its pres-
ence on the surface of gold nanoparticles might interfere
with the MTT assay, thus leading to an overestimation of
the viability data and to the conclusion that AuNPs exert
only a mild toxicity or, in some cases, no toxicity at all in
the cell lines A549 and NCIH441. Consequently, the cyto-
toxicity induced by AuNPs was further investigated by Ki-
67 and LDH release assay. By Ki-67 assay it has been
shown that the sodium citrate-nanoparticles AuS0302-
RIS02 and AuS0302-RIS04 impaired (up to 50–70%
reduction) the proliferation of the cell lines A549 and
NCIH441. A slightly reduced proliferation was also meas-
ured following exposure to the sample AuS0302-RIT,
which presents a significantly reduced amount of sodium
citrate as surface contaminant. Investigating the amount
of lactate dehydrogenase (LDH) released upon exposure
to AuNPs we have shown that the major effects are detect-
able after 72 hr treatment. In addition, in the cell lines
A549 and NCIH441 a dose-dependent LDH release was
observed. Summarizing, we demonstrated the cytotoxic
potential of gold nanoparticles in alveolar type-II-like cell
lines using different assays (MTT, Ki-67 and LDH release)
and different end-points (cell viability, cell proliferation
and membrane integrity).
Internalization of gold nanoparticles
The sample AuS0302-RIT, compared to AuS0302-RIS02
and AuS0302-RIS04 gold nanoparticles with an excess of
sodium citrate, induced a mild toxicity, as observed by
MTT and Ki-67 assay, and induced a lower LDH release in
Comparison of the cytotoxicity induced by gold nanoparticles in the cell lines A549 and NCIH441: lactate dehydrogenase releaseFigur  4
Comparison of the cytotoxicity induced by gold nanoparticles in the cell lines A549 and NCIH441: lactate 
dehydrogenase release. The cell lines A549 (A) and NCIH441 (B) in the logarithmic growth phase were exposed to AuNPs 
for 24, 48 and 72 hr. The gold-induced cytotoxicity was measured by LDH release assay. Each result represents the mean LDH 
release ± standard deviation (SD) of three independent experiments and each of these was performed in triplicate.Page 7 of 12
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reduced cytotoxicity of AuS0302-RIT was due to a defec-
tive internalization of the particles, confluent A549 and
NCIH441 monolayers were incubated for 3 hr in the pres-
ence of AuNPs (0.3 mM and 1 mM in complete cell cul-
ture medium). At the end of the exposure time, cells were
fixed and then analyzed by transmission electron micros-
copy. Figure 5 shows the comparison between the inter-
nalization of the gold nanoparticles AuS0302-RIT and
AuS0302-RIS02 under different cell culture conditions. At
37°C, AuS0302-RIT nanoparticles were internalized by
both A549 (Figure 5E) and NCIH441 (Figure 5I) cell lines,
and the pattern was comparable to the uptake of the gold
nanoparticles AuS0302-RIS02 (Figure 5G and 5K). In
addition, the internalized gold particles were observed in
membrane-bound vesicles (Figure 5F, H, J and 5L),
mostly localized in the perinuclear region. Freely dis-
persed nanoparticles in the cytosol were not detected,
even when cells were exposed to AuS0302-RIS04 nano-
particles (data not shown). Using an analogous experi-
mental procedure, cells were exposed to ice-cold gold
nanoparticles (0.3 mM and 1 mM solutions in complete
cell culture medium) and incubated for 3 hr at 4°C. The
absence of AuS0302-RIT (Figure 5A and 5C), AuS0302-
RIS02 (Figure 5B and 5D) and AuS0302-RIS04 (data not
shown) uptake in the cell lines A549 and NCIH441 at 4°C
suggests that gold nanoparticles are internalized by active
endocytosis. These observations on the intracellular local-
ization of AuNPs are in contrast with Rothen-Rutishauser
et al. [32], who demonstrated that in a cell culture model
of the airway epithelium gold nanoparticles were found
freely dispersed in the cytoplasm, and occasionally in the
nuclei, rather than localized in membrane-bound vesicles
as observed for titanium dioxide particles. However, our
results are consistent with previous data showing that in
human dermal fibroblasts [25], leukemia cells [26],
human hepatocellular cells [30], rat alveolar macrophages
and epithelial type-I cells [33], and in mouse dendritic
cells and fibroblasts [34], gold nanoparticles are internal-
ized and stored in endocytic vesicles. The uptake of gold
nanoparticles seems to depend on the surface structure of
NPs. In fact, water-soluble gold nanoparticles coated with
ordered or disordered amphiphilic ligand shells were
taken up differently by mouse dendritic cells (DC2.4 cell
line) [34]. Verma et al. [34] have shown that AuNPs
coated with ordered striated anionic and hydrophobic
groups were internalized without disrupting the mem-
brane integrity and particles were observed freely dis-
persed in the cytosol. On the contrary, gold particles
coated with the same anionic and hydrophobic ligands,
but randomly distributed over the particle surface, were
stored in endosomal/lysosomal compartments. From our
TEM study we observed that AuNPs were easily taken up
by the cell lines A549 and NCIH441, and the uptake was
independent of the presence or absence of contaminants
on the particle surface. In addition, we observed a compa-
rable internalization of AuNPs, although they had a rela-
tively small size (9.5 – 11.2 – 25 nm). These data are in
contrast with those made by Chithrani and Chan [35] in
HeLa cells. They investigated the uptake of gold particles
with a size range of 14 – 100 nm, and they concluded that
the better uptake was observed for particles with a diame-
ter of 50 nm. In fact, Chithrani and Chan have quantitated
the uptake of AuNPs in HeLa cells and they demonstrated
that, in the experimental conditions they applied, small
particles (14 nm), as well as larger NPs (100 nm), are
poorly internalized. Electron microscopy images clearly
show that in HeLa cells both 14 and 100 nm AuNPs were
internalized in cytoplasmic vesicles and they appeared
monodispersed. On the contrary, 30 nm and 50 nm par-
ticles appeared to agglomerate. Nevertheless, the aim of
our study was to investigate if the surface coating influ-
ences the uptake of AuNPs in ATII-like cells. From the
observations we made it is clear that even if toxicity seems
to depend on the surface contaminants, the uptake of
AuNPs is not affected by the presence or absence of
sodium citrate on the particle surface.
Conclusion
In conclusion, our results suggest that the presence of con-
taminants, such as sodium citrate, affects the viability and
the proliferation of the human alveolar type-II-like cell
lines A549 and NCIH441 in vitro, rather than the size of
the particles. Dialyzed and purified gold nanoparticles
could induce a milder cytotoxicity in A549 and NCIH441
cells compared to the particles with an excess of sodium
citrate. In addition, the absence of contaminants does not
influence the uptake of gold particles. Our data support
the fact that the human ATII-like cell lines A549 and
NCIH441 internalize gold NPs by active endocytosis inde-
pendent of the size and of the presence or absence of con-
taminants in solution. Moreover, the uptake can be
inhibited by exposing the cells to low temperature. Fur-
ther studies are underway to elucidate the uptake mecha-
nism and the intracellular fate of gold nanoparticles.
Methods
Synthesis and characterization of gold nanoparticles
Gold nanoparticles (AuNPs) were synthesized in water by
reducing tetrachloroauric acid (HAuCl4, purchased by
Colorobbia S.p.A., Italy) in a sodium citrate solution con-
taining polyvinylpirrolidone (PVP; (C6H9NO)n) as stabi-
lizing agent [23,36]. To produce nanoparticles which
retain their physicochemical properties over time and do
not aggregate, the wet chemical synthesis of AuNPs via
reduction of gold salts was employed [37]. A water solu-
tion of 0.5% (w/w) PVP, purchased by Toscochimica
(Prato, Italy), was heated to 60°C and HAuCl4, character-
ized by a gold content of 30%, as determined by induc-
tively coupled plasma-atomic emission spectrometryPage 8 of 12
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Internalization of gold nanoparticles in the cell lines A549 and NCIH441Figure 5
Internalization of gold nanoparticles in the cell lines A549 and NCIH441. The human ATII-like cell lines A549 and 
NCIH441 were incubated in the presence of AuS0302-RIT and AuS0302-RIS02 nanoparticles. After 3 hr incubation, cells were 
fixed and analyzed by transmission electron microscopy (TEM). At 37°C, 0.3 mM AuS0302-RIT (E-F and I-J) and AuS0302-
RIS02 (G-H and K-L) were taken up by the cell lines A549 and NCIH441. Gold nanoparticles were observed localized in intra-
cellular membrane-bound vesicles and not freely dispersed in the cytoplasm. In parallel, cells were treated with ice-cold nano-
particle solutions and incubated at 4°C for 3 hr. None of the gold nanoparticles investigated was taken up by the A549 (A and 
B) and by the NCIH441 (C and D) cells at 4°C, as shown by TEM, suggesting that particles are internalized by active endocyto-
sis. Size bar: 1 μm.
Particle and Fibre Toxicology 2009, 6:18 http://www.particleandfibretoxicology.com/content/6/1/18(ICP-AES), was added to obtain a final gold concentration
of 0.2% (w/w). To this intermediate compound, an aque-
ous solution of sodium citrate (16.5% w/w) was added
and the resulting product was kept at 60°C for 1 hr and
afterwards air-cooled to room temperature. The resulting
sample was named AuS0302 and was characterized by the
presence of an excess of sodium citrate and a particle
diameter of 9.5 nm as shown by STEM images. A second
series of gold nanoparticles with larger average size (sam-
ples AuS0302-RIS02 and AuS0302-RIS04) were prepared
as follows: to synthesize AuS0302-RIS02, AuS0302 was
used as initial seed (25% of the total gold content) and
mixed with PVP. The solution was heated to 60°C and
suitable amounts of tetrachloroauric acid were added to
maintain the final gold concentration at 0.2% (w/w). As
final step, sodium citrate was added and the solution kept
at 60°C, prior to cooling to RT. The batch AuS0302-RIS04
was prepared using a similar procedure, but the com-
pound AuS0302-RIS02 was used as seed for this synthesis.
To remove excess of sodium citrate from the sample
AuS0302, tangential flow dialysis was performed using an
Amicon system (Millipore) equipped with Biomax mem-
brane (cut-off 10.000 KDa) (Millipore). The total volume
dialysed was 36 times the initial volume and the resulting
samples, which had only about 8% sodium citrate on the
particle surface, was termed AuS0302-RIT.
Cell culture and Cytotoxicity assays
Cell culture
The human alveolar type-II (ATII)-like cell lines A549
(ATCC number CCL-185,) and NCIH441 (ATCC number
HTB-174) were purchased by LGC Promochem (Wesel,
Germany). Cells were cultured in complete cell culture
medium composed of RPMI 1640 with L-Glutamine (Inv-
itrogen Corporation, Germany) supplemented with 10%
(v/v) Fetal Bovine Serum (Sigma Aldrich, Germany) and
1% (v/v) 10000 U/ml Penicillin and 10000 U/ml Strepto-
mycin (Invitrogen Corporation, Germany). Cells were
maintained under standard cell culture conditions (5%
CO2, 95% humidity and 37°C in HERAEUS incubators,
Germany) and passaged weekly.
Cytotoxicity assays
The cytotoxicity induced by gold nanoparticles was inves-
tigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assay, Ki-67 assay and lactate
dehydrogenase (LDH) release assay. All tests were per-
formed using sub-confluent cells in the logarithmic
growth phase. Cells (4.0 × 104 A549 cells/ml and 1.5 × 105
NCIH441 cells/ml; 100 μl/well in complete cell culture
medium) were seeded in 96 well plates (TPP, Switzer-
land). Cells were then exposed for 24, 48 and 72 hr to
concentrations of gold nanoparticles ranging from 0 mM
to 0.7 mM. Nanoparticles were dispersed in complete cell
culture medium RPMI 1640 with L-Glutamine (Invitro-
gen Corporation, Germany), with 5% Fetal Bovine Serum
(Sigma Aldrich, Germany) and 1% (v/v) 10000 U/ml Pen-
icillin and 10000 U/ml Streptomycin (Invitrogen Corpo-
ration, Germany). For each gold nanoparticle a blank
solution was tested and no cytotoxicity could be observed.
A 10% DMSO solution was used as positive control. Three
independent experiments and 3 replicates for each exper-
iment were performed.
In the MTT assay, after 60 hr incubation cell culture
medium was replaced with fresh medium containing
AuNPs at concentrations ranging from 0 mM to 0.7 mM.
After 24, 48 and 72 hr continuous exposure to AuNPs,
medium was removed, cells were washed with PBS and
then incubated with cell culture medium containing 20%
MTT solution (stock solution 5 mg MTT/ml PBS; Sigma
Aldrich, Germany). After 3 hr incubation at 37°C and 5%
CO2, 100 μl lysis buffer (20 g SDS dissolved in 50 ml
ddH2O and supplemented with 50 ml N, N-Dimethylfor-
mamide. pH 4.7) per well was added. Cells were further
incubated overnight and the absorbance was measured by
spectrophotometry at λ1 = 620 nm and λ2 = 750 nm.
Results were analyzed as the average of viability (% of the
untreated control) ± Standard Deviation (SD).
For the Ki-67 assay, sub-confluent cells were exposed to
gold nanoparticles for 24–72 hr, fixed using 1% (v/v)
methanol/ethanol solution and washed five times in PBS.
Fixed cells were permeabilized with 0.1% Triton-x 100 (v/
v) in PBS, and after 10 minutes of permeabilization at
room temperature, cells were washed three times in a
solution containing PBS/0.05% Tween-20 (v/v) and incu-
bated (45 minutes at 37°C on a rotating plate) with 1 μg/
ml mouse anti-human Ki-67 antibody (clone MIB-1;
DAKO, Germany). Cells were then incubated for 45 min-
utes at 37°C with anti-mouse IgG1 peroxidase (DAKO,
Germany), and washed with PBS/0.05% Tween-20. After-
wards cells were incubated 10–20 minutes at 37°C with a
solution (170 μl/well) composed by 5 mL 10× citric buffer
mixed with 45 mL water, 20 μL 30% oxygen peroxide and
o-Phenylenediamine. The solution was pipetted in a new
96 well plate containing 3 M chloridric acid (HCl) (50 μl/
well), and the fluorescence was detected by spectropho-
tometry at 492 nm. Results are expressed as the mean
value of cellular proliferation (% of the untreated control)
± Standard Deviation (SD).
In the LDH assay (Promega Corporation, Germany) 50
μl/well supernatant, collected after exposing the cell lines
A549 and NCIH441 to AuNPs, were incubated with an
equivalent volume of substrate solution. After incubating
the plate for 30 minutes at RT, 50 μl/well stop solution
was pipetted and data were acquired by spectrophotome-
try at 490 nm. Results are expressed as mean LDH releasePage 10 of 12
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mum LDH release at 490 nm ± Standard Deviation (SD).
Uptake and transmission electron microscopy studies
The human ATII-like cell lines A549 and NCIH441 were
seeded on fibronectin-coated Thermanox cover slips
(NUNC – Thermo Fisher Scientific, Germany) and culti-
vated until confluent. For the incubation at 37°C, cells
were exposed to 0.3 mM and 1 mM gold nanoparticles
AuS0302-RIT, AuS0302-RIS02 and AuS0302-RIS04. For
the incubation at 4°C, cells were first pre-cooled for 30
minutes at 4°C, and then exposed to ice-cold AuNPs in
the same concentration as for the 37°C test. For both cell
incubation conditions, after 3 hr exposure to AuNPs cells
were fixed in 3.7% (v/v) paraformaldehyde in PBS (20
min at RT). Afterwards cells were prepared for transmis-
sion electron microscopy analysis as follows: cells were
fixed in 1% (w/v) osmium tetroxide for 2 hr and dehy-
drated in ethanol. Cells were passaged through propylene
oxide, then samples were embedded in agar-100 resin
(PLANO, Germany) and polymerized at 60°C for 48 hr.
Ultrathin sections were cut with an ultramicrotome (Leica
Microsystems, Germany), placed onto copper grids and
stained with 1% (w/v) uranyl acetate in alcoholic solution
and lead citrate. Ultrastructural analysis and photomicro-
scopy were performed with a transmission electron micro-
scope EM 410 (Philips; Eindhoven, Netherlands).
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